Treatment of chronic myelogenous leukemia with interferon α. A decade of experience;THERAPIE DER CHRONISCHEN MYELOISCHEN LEUKAMIE MIT INTERFERON α. ERFAHRUNGEN AUS EINEM JAHRZEHNT

Medizinische Klinik

Volumn 91, Issue SUPPL. 3, 1996, Pages 18-23+25

  Freund, M ^a   Heussner, P ^a   Hild, F ^a   Nowak, R ^a   Grote Metke, A ^a   Diedrich, H ^a   Koch, O ^a   Otremba, B ^a   Von Wussow, P ^a   Kleine, H D ^a   Meran, J ^a   Link, H ^a   Hinrichs, H F ^a   Balleisen, L ^a   Fonatsch, C ^a   Poliwoda, H ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CYTARABINE; CYTARABINE 5' STEARYLPHOSPHATE; GAMMA INTERFERON; HYDROXYUREA; ANTINEOPLASTIC AGENT;

ADVERSE DRUG REACTION; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; ARTICLE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; LONG TERM CARE; MORTALITY; MULTIMODALITY CANCER THERAPY; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; CYTARABINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; LONG-TERM CARE; SURVIVAL RATE;

EID: 0029941813     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)